Logo image of ORGO

ORGANOGENESIS HOLDINGS INC (ORGO) Stock Overview

USA - NASDAQ:ORGO - US68621F1021 - Common Stock

4.29 USD
+0.06 (+1.42%)
Last: 10/3/2025, 8:00:02 PM
4.29 USD
0 (0%)
After Hours: 10/3/2025, 8:00:02 PM

ORGO Key Statistics, Chart & Performance

Key Statistics
52 Week High6.71
52 Week Low2.61
Market Cap544.23M
Shares126.86M
Float67.44M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.05
PEN/A
Fwd PE13.57
Earnings (Next)11-10 2025-11-10/amc
IPO12-02 2016-12-02
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


ORGO short term performance overview.The bars show the price performance of ORGO in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5 10 -10

ORGO long term performance overview.The bars show the price performance of ORGO in the last 1, 2 and 3 years. 1 year 2 years 3 years 20 40 60 80

The current stock price of ORGO is 4.29 USD. In the past month the price decreased by -14.2%. In the past year, price increased by 39.29%.

ORGANOGENESIS HOLDINGS INC / ORGO Daily stock chart

ORGO Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 22.09 413.22B
AMGN AMGEN INC 13.66 160.37B
GILD GILEAD SCIENCES INC 14.56 139.83B
VRTX VERTEX PHARMACEUTICALS INC 23.81 103.40B
REGN REGENERON PHARMACEUTICALS 13.15 63.59B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 59.82B
ARGX ARGENX SE - ADR 86.3 48.96B
ONC BEONE MEDICINES LTD-ADR 5.55 37.77B
INSM INSMED INC N/A 33.22B
BNTX BIONTECH SE-ADR N/A 25.36B
BIIB BIOGEN INC 9.99 23.44B
NTRA NATERA INC N/A 22.97B

About ORGO

Company Profile

ORGO logo image Organogenesis Holdings, Inc. is a regenerative medical company, which engages in the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. The company is headquartered in Canton, Massachusetts and currently employs 869 full-time employees. The company went IPO on 2016-12-02. The company offers a portfolio of regenerative products to address patient needs across the continuum of care. Its wound care products include Apligraf for the treatment of venous leg ulcers and diabetic foot ulcers (DFUs); Dermagraft for the treatment of DFUs; PuraPly AM as an antimicrobial barrier, cross-linked with extracellular matrix scaffold for a variety of wound types; and Affinity, Novachor and NuShield placental allografts to address a variety of wound sizes and types as a protective barrier and extracellular matrix scaffold. Its sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM and PuraPly SX for the management of open wounds in a surgical setting.

Company Info

ORGANOGENESIS HOLDINGS INC

85 Dan Rd

Canton MASSACHUSETTS 02021 US

CEO: Gary S. Gillheeney Sr.

Employees: 869

ORGO Company Website

ORGO Investor Relations

Phone: 17815750775

ORGANOGENESIS HOLDINGS INC / ORGO FAQ

What is the stock price of ORGANOGENESIS HOLDINGS INC today?

The current stock price of ORGO is 4.29 USD. The price increased by 1.42% in the last trading session.


What is the ticker symbol for ORGANOGENESIS HOLDINGS INC stock?

The exchange symbol of ORGANOGENESIS HOLDINGS INC is ORGO and it is listed on the Nasdaq exchange.


On which exchange is ORGO stock listed?

ORGO stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for ORGANOGENESIS HOLDINGS INC stock?

8 analysts have analysed ORGO and the average price target is 8.16 USD. This implies a price increase of 90.21% is expected in the next year compared to the current price of 4.29. Check the ORGANOGENESIS HOLDINGS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is ORGANOGENESIS HOLDINGS INC worth?

ORGANOGENESIS HOLDINGS INC (ORGO) has a market capitalization of 544.23M USD. This makes ORGO a Small Cap stock.


How many employees does ORGANOGENESIS HOLDINGS INC have?

ORGANOGENESIS HOLDINGS INC (ORGO) currently has 869 employees.


What are the support and resistance levels for ORGANOGENESIS HOLDINGS INC (ORGO) stock?

ORGANOGENESIS HOLDINGS INC (ORGO) has a support level at 4.19 and a resistance level at 4.8. Check the full technical report for a detailed analysis of ORGO support and resistance levels.


Is ORGANOGENESIS HOLDINGS INC (ORGO) expected to grow?

The Revenue of ORGANOGENESIS HOLDINGS INC (ORGO) is expected to grow by 4.04% in the next year. Check the estimates tab for more information on the ORGO EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy ORGANOGENESIS HOLDINGS INC (ORGO) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ORGANOGENESIS HOLDINGS INC (ORGO) stock pay dividends?

ORGO does not pay a dividend.


When does ORGANOGENESIS HOLDINGS INC (ORGO) report earnings?

ORGANOGENESIS HOLDINGS INC (ORGO) will report earnings on 2025-11-10, after the market close.


What is the Price/Earnings (PE) ratio of ORGANOGENESIS HOLDINGS INC (ORGO)?

ORGANOGENESIS HOLDINGS INC (ORGO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.05).


What is the Short Interest ratio of ORGANOGENESIS HOLDINGS INC (ORGO) stock?

The outstanding short interest for ORGANOGENESIS HOLDINGS INC (ORGO) is 16.11% of its float. Check the ownership tab for more information on the ORGO short interest.


ORGO Technical Analysis

ChartMill assigns a technical rating of 5 / 10 to ORGO. When comparing the yearly performance of all stocks, ORGO is one of the better performing stocks in the market, outperforming 80.6% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

ORGO Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to ORGO. ORGO has only an average score on both its financial health and profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ORGO Financial Highlights

Over the last trailing twelve months ORGO reported a non-GAAP Earnings per Share(EPS) of -0.05. The EPS decreased by -225% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -3.38%
ROE -4.32%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-350%
Sales Q2Q%-22.44%
EPS 1Y (TTM)-225%
Revenue 1Y (TTM)-4.2%

ORGO Forecast & Estimates

8 analysts have analysed ORGO and the average price target is 8.16 USD. This implies a price increase of 90.21% is expected in the next year compared to the current price of 4.29.

For the next year, analysts expect an EPS growth of -136% and a revenue growth 4.04% for ORGO


Analysts
Analysts85
Price Target8.16 (90.21%)
EPS Next Y-136%
Revenue Next Year4.04%

ORGO Ownership

Ownership
Inst Owners55.08%
Ins Owners31.49%
Short Float %16.11%
Short Ratio14.2